Product Description: PT-2385 is a selective HIF-2α inhibitor with a Ki of less than 50 nM[1][2].
Applications: Cancer-programmed cell death
Formula: C17H12F3NO4S
References: [1]Eli Wallace, Ph.D. PT2385: HIF-2α Antagonist for the Treatment of VHL Mutant ccRCC. 12th International VHL Medical Symposium April 8, 2016./[2]Xie C, et al. Activation of intestinal hypoxia-inducible factor 2α during obesity contributes to hepatic steatosis. Nat Med. 2017 Nov;23(11):1298-1308./[3]Wallace EM, et al. A Small-Molecule Antagonist of HIF2α Is Efficacious in Preclinical Models of Renal Cell Carcinoma. Cancer Res. 2016 Sep 15;76(18):5491-500.
CAS Number: 1672665-49-4
Molecular Weight: 383.34
Compound Purity: 99.95
Research Area: Cancer
Solubility: DMSO : ≥ 50 mg/mL
Target: HIF/HIF Prolyl-Hydroxylase